Brown Tumor Management in End Stage Renal Disease Patients on Chronic Dialysis: Case Reports and Literature Review

2014 ◽  
Vol 25 (2) ◽  
pp. 20
Author(s):  
A. M. Makusidi ◽  
Anand Yuvaraj ◽  
Milly Mathew ◽  
Sanjeev Nair ◽  
P. Nagarajan ◽  
...  
Keyword(s):  
Literature Review ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Case Reports ◽  
Chronic Dialysis ◽  
Brown Tumor ◽  
Tumor Management ◽  
Stage Renal Disease ◽  
End Stage

End-Stage Renal Disease Patients with Low Serum Albumin: Is Peritoneal Dialysis an Option?

2019 ◽  
Vol 39 (6) ◽  
pp. 562-567 ◽  
Author(s):  
Tripti Singh ◽  
Brad C. Astor ◽  
Sana Waheed
Keyword(s):  
Peritoneal Dialysis ◽  
Renal Disease ◽  
Serum Albumin ◽  
End Stage Renal Disease ◽  
Chronic Dialysis ◽  
Lower Mortality ◽  
Dialysis Modality ◽  
Stage Renal Disease ◽  
End Stage ◽  
Low Serum

Introduction Low serum albumin is associated with high mortality in patients with end-stage renal disease (ESRD) on chronic dialysis. Clinicians are reluctant to offer peritoneal dialysis (PD) as an option for dialysis for patients with low serum albumin due to concerns of loss of albumin with PD, but evidence supporting differences in outcomes is limited. We evaluated mortality based on dialysis modality in patients with very low serum albumin (< 2.5 g/dL). Methods We analyzed United States Renal Data System (USRDS) data from 2010 to 2015 to assess mortality by modality adjusted for age, sex, race, employment, number of comorbidities, and year of dialysis initiation. Results Low serum albumin (< 2.5 g/dL) was present in 78,625 (19.9%) of 395,656 patients with ESRD on chronic dialysis. Patients with low serum albumin were less likely to use PD as their first modality than those with higher albumin (3.1% vs 10.9%; p < 0.001). Use of PD was associated with lower mortality compared with hemodialysis (HD) (hazard ratio [HR] = 0.88, 95% confidence interval [CI] 0.81 – 0.95, p < 0.05) in patients with low serum albumin. This difference was more pronounced in patients who had glomerulonephritis (HR = 0.72) or hypertension (HR = 0.81) than in those with end-stage renal disease (ESRD) due to diabetes mellitus or other causes. Conclusion Peritoneal dialysis is less likely to be the first dialysis modality in patients with low serum albumin requiring dialysis. However, PD is associated with lower mortality than HD in patients with low serum albumin on dialysis. We recommend advocating the use of PD in patients with low serum albumin.

Formal literature review of quality-of-life instruments used in end-stage renal disease

2000 ◽  
Vol 36 (2) ◽  
pp. 327-336 ◽  
Author(s):  
Kathleen A. Cagney ◽  
Albert W. Wu ◽  
Nancy E. Fink ◽  
Mollie W. Jenckes ◽  
Klemens B. Meyer ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Literature Review ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
Quality Of Life Instruments

A thoracic vertebral brown tumor presenting with paraparesis in a patient with end-stage renal disease

2016 ◽  
Vol 31 (6) ◽  
pp. 635-637 ◽  
Author(s):  
Bilgehan Solmaz ◽  
Necati Tatarlı ◽  
Feray Günver ◽  
Türker Emre
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Brown Tumor ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document